New fiber strains to complement the Company’s record setting Dragon Silk Technology
ANN ARBOR, Mich., – October 30, 2017- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)
(“Company”), the leading developer of spider silk based fibers, announced that it is now working to create a set of new custom designed transgenic silkworms under its contract with the US Army. The Company is working with material performance objectives, defined by the customer, to develop entirely new genetically enhanced silkworm strains.
These new silk polymers will be evaluated against defined performance requirements and the best performing materials will be scaled up to produce upwards of 100kgs of silk thread. The Company expects the new strains to complement its record setting Dragon Silk fibers, but, with an eye on additional targeted applications, the fibers will be designed to generate even higher tensile strength. As a result, these new enhanced fibers should provide outstanding performance in protective textile applications.
“This project is an excellent opportunity for us to demonstrate the incredible potential and power of engineered silk,” said COO Jon Rice. “Tailoring the focus of our design efforts directly to a materials performance requirements is a perfect example of the amazing flexibility, and possibilities, of engineered proteins. These new transgenics will be the beginning of our Enhanced Tactical Fiber (ETF) line of materials. While a monumental moment for the Company, it is but one of many new and exciting opportunities for, spider silk, the Company, and our shareholders.”
To support this effort, the Company is hiring additional research and production staff and rapidly building out its in house lab capabilities at its Michigan based research and production center.
To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,”
“foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC